Education
About Us
Working with TipRanks
Follow Us
Vivosim Labs Inc (CH:ONVO)
:ONVO
ONVO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$418.80 - $418.80
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$4.12M
Enterprise Value$5.59M
Total Cash (Recent Filing)$1.16M
Total Debt (Recent Filing)$1.06M
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding836,673
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.24
Price to Sales (P/S)N/A
P/FCF Ratio-1.49
Enterprise Value/Market Cap1.36
Enterprise Value/Revenue13.72
Enterprise Value/Gross Profit47.74
Enterprise Value/Ebitda-0.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
VivoSim Labs News
PremiumCompany Announcements
Organovo Holdings Rebrands to VivoSim Labs, Inc.
PremiumCompany Announcements
Organovo Holdings Announces Transition to VivoSim Labs
PremiumCompany Announcements
Organovo Holdings Expects to Meet Nasdaq Listing Requirements
PremiumCompany Announcements
Organovo Holdings Completes Sale of FXR Program to LillyOptions Prices
Currently, No data available
---
Ownership Overview
24.63% Insiders
6.74%
Mutual Funds
1.38% Other Institutional Investors
65.94% Public Companies and
Individual Investors
ONVO FAQ
What was Vivosim Labs Inc’s price range in the past 12 months?
Vivosim Labs Inc lowest stock price was $418.80 and its highest was $418.80 in the past 12 months.
What is Vivosim Labs Inc’s market cap?
Vivosim Labs Inc’s market cap is $4.12M.
When is Vivosim Labs Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vivosim Labs Inc’s earnings last quarter?
Vivosim Labs Inc released its earnings results on May 22, 2019. The company reported -$20.268 earnings per share for the quarter, missing the consensus estimate of N/A by -$20.268.
Is Vivosim Labs Inc overvalued?
According to Wall Street analysts Vivosim Labs Inc’s price is currently Overvalued.
Does Vivosim Labs Inc pay dividends?
Vivosim Labs Inc does not currently pay dividends.
What is Vivosim Labs Inc’s EPS estimate?
Vivosim Labs Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vivosim Labs Inc have?
Vivosim Labs Inc has 836,673 shares outstanding.
What happened to Vivosim Labs Inc’s price movement after its last earnings report?
Vivosim Labs Inc reported an EPS of -$20.268 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Vivosim Labs Inc?
Currently, no hedge funds are holding shares in CH:ONVO
Company Description
Vivosim Labs Inc
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.